AVR560 - A New HCV Inhibitor that blocks early stages of viral infection
Latest Information Update: 17 May 2016
At a glance
- Drugs AVR 560 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 15 May 2014 Status changed from recruiting to completed, according to an Alla Chem media release.
- 26 Nov 2013 New trial record